Related Experiment Video
Updated: Jul 17, 2026

Design of a Cyclic Pressure Bioreactor for the Ex Vivo Study of Aortic Heart Valves
Published on: August 23, 2011
Decision guidelines for prophylactic replacement of Björk-Shiley convexo-concave heart valves: impact on clinical
M J van Gorp1, E W Steyerberg, Y Van der Graaf
1Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands.
Insights
Prophylactic replacement of Björk-Shiley convexo-concave (BScc) valves largely followed guidelines in the Netherlands. Decision-analytic guidelines, updated and rigorously implemented, can guide clinical practice for complex cardiac valve decisions.
Area of Science:
- Cardiology
- Medical Decision Making
- Public Health
Background:
- Björk-Shiley convexo-concave (BScc) valves pose a risk of outlet strut fracture, necessitating consideration of prophylactic replacement.
- Epidemiological and decision-analytic guidelines aim to inform BScc valve replacement strategies.
Purpose of the Study:
- To assess the impact of epidemiological and decision-analytic guidelines on actual BScc valve replacement practices.
- To evaluate the concordance between guideline recommendations and clinical decisions regarding BScc valve replacement.
Main Methods:
- Retrospective cohort study of 2263 Dutch BScc patients with a mean follow-up of 11.3 years.
- Analysis of outlet strut fracture, mortality, and BScc valve replacement rates.
- Calculation of expected differences in life expectancy (LE) with and without valve replacement based on 1992 guidelines for surviving patients.
Main Results:
- During 8 years of follow-up, 40% of patients died, and 11 experienced outlet strut fracture.
- 10% of patients underwent BScc valve replacement, with increased rates after guideline introduction.
- Patients with an estimated gain in LE were significantly more likely to undergo replacement (HR, 6.6).
Conclusions:
- BScc heart valve replacement in the Netherlands generally aligned with established guidelines.
- Individualized guidelines, supported by robust epidemiological data and rigorous implementation, can effectively shape clinical practice in complex scenarios.
Background:
Because of risk of outlet strut fracture, prophylactic replacement should be considered for Björk-Shiley convexo-concave (BScc) valve recipients. We assessed the effects of epidemiological and decision-analytic guidelines on actual BScc valve replacement.
Methods And Results:
We performed a retrospective cohort study including all 2263 Dutch BScc patients with a mean follow-up of 11.3 years (range, 0 to 23 years). Outcomes were outlet strut fracture, mortality, and BScc valve replacement. For the surviving patients in 1992 (n=1330), we calculated the expected differences in life expectancy (LE) with and without BScc valve replacement according to decision guidelines developed in 1992. Differences in LE were compared with actual replacements. During 8 years of follow-up, there were 494 deaths (40%), and 11 patients had suffered outlet strut fracture. Of 1330 patients, 96 (10%) had undergone BScc valve replacement, particularly in years after introduction of initial and updated guidelines. One hundred seventeen patients (9%) had an estimated gain in LE after BScc valve replacement. These patients were more likely to undergo replacement than patients with an estimated loss of LE (hazard ratio, 6.6; 95% CI, 4.4 to 10; P<0.0001). A loss in LE after reoperation was predicted for 8 of 11 patients who experienced outlet strut fracture after guidelines were available.
Conclusions:
Valve replacement for BScc heart valve patients was largely in concordance with guidelines in the Netherlands. Individualized guidelines that are based on high-quality epidemiological data and are updated and implemented rigorously can influence clinical practice in complex decision problems.
Related Concept Videos
Mitral Valve Prolapse II: Assessment and Management
Mitral Valve Prolapse III: Nursing Management
Mitral Stenosis III: Medical Management
Mitral Stenosis IV: Nursing Management
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy VII: Pre and Post Operative Nursing Management

